This is the first and only FDA-approved rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear days after infection and prior to HIV-1/2 antibodies, according to the company.
Read More
Products range from a smartphone-based reader to a rapoid molecular diagnostic test for C. diff.
Read More
AtomoRapid is a convenient, handheld rapid blood test device that simplifies procedures, eliminating the need for complex test kits containing multiple items.
Read More
Products run the gamut from controls to analyzers, for environments ranging from community screening events to critical care units.
Read More
These instruments have footprints that allow them to be placed in near-patient testing sites or at the patient’s bedside.
Read More